Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo data.


Journal

PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922

Informations de publication

Date de publication:
10 Sep 2024
Historique:
received: 19 04 2024
accepted: 21 08 2024
medline: 10 9 2024
pubmed: 10 9 2024
entrez: 10 9 2024
Statut: aheadofprint

Résumé

While most individuals suffer progressive disease following HIV infection, a small fraction spontaneously controls the infection. Although CD8 T-cells have been implicated in this natural control, their mechanistic roles are yet to be established. Here, we combined mathematical modeling and analysis of previously published data from 16 SIV-infected macaques, of which 12 were natural controllers, to elucidate the role of CD8 T-cells in natural control. For each macaque, we considered, in addition to the canonical in vivo plasma viral load and SIV DNA data, longitudinal ex vivo measurements of the virus suppressive capacity of CD8 T-cells. Available mathematical models do not allow analysis of such combined in vivo-ex vivo datasets. We explicitly modeled the ex vivo assay, derived analytical approximations that link the ex vivo measurements with the in vivo effector function of CD8-T cells, and integrated them with an in vivo model of virus dynamics, thus developing a new learning framework that enabled the analysis. Our model fit the data well and estimated the recruitment rate and/or maximal killing rate of CD8 T-cells to be up to 2-fold higher in controllers than non-controllers (p = 0.013). Importantly, the cumulative suppressive capacity of CD8 T-cells over the first 4-6 weeks of infection was associated with virus control (Spearman's ρ = -0.51; p = 0.05). Thus, our analysis identified the early cumulative suppressive capacity of CD8 T-cells as a predictor of natural control. Furthermore, simulating a large virtual population, our model quantified the minimum capacity of this early CD8 T-cell response necessary for long-term control. Our study presents new, quantitative insights into the role of CD8 T-cells in the natural control of HIV infection and has implications for remission strategies.

Identifiants

pubmed: 39255323
doi: 10.1371/journal.pcbi.1012434
pii: PCOMPBIOL-D-24-00661
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1012434

Informations de copyright

Copyright: © 2024 Vemparala et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Bharadwaj Vemparala (B)

Department of Chemical Engineering, Indian Institute of Science, Bengaluru, India.

Vincent Madelain (V)

Université Paris Cité, IAME, INSERM, Paris, France.

Caroline Passaes (C)

Institut Pasteur, Université Paris Cité, Viral Reservoirs and Immune Control Unit, Paris, France.
CEA, Université Paris-Saclay, INSERM U1184, Immunology of Viral, Autoimmune, Hematologic and Bacterial Diseases (IMVAHB), IDMIT Department/ IBFJ, Fontenay-aux-Roses, France.

Antoine Millet (A)

INSERM U1016, CNRS UMR8104, Université Paris Cité Institut Cochin, Paris, France.

Véronique Avettand-Fenoel (V)

INSERM U1016, CNRS UMR8104, Université Paris Cité Institut Cochin, Paris, France.

Ramsès Djidjou-Demasse (R)

MIVEGEC, University of Montpellier, CNRS, IRD, Montpellier, France.

Nathalie Dereuddre-Bosquet (N)

CEA, Université Paris-Saclay, INSERM U1184, Immunology of Viral, Autoimmune, Hematologic and Bacterial Diseases (IMVAHB), IDMIT Department/ IBFJ, Fontenay-aux-Roses, France.

Roger Le Grand (R)

CEA, Université Paris-Saclay, INSERM U1184, Immunology of Viral, Autoimmune, Hematologic and Bacterial Diseases (IMVAHB), IDMIT Department/ IBFJ, Fontenay-aux-Roses, France.

Christine Rouzioux (C)

INSERM U1016, CNRS UMR8104, Université Paris Cité Institut Cochin, Paris, France.

Bruno Vaslin (B)

CEA, Université Paris-Saclay, INSERM U1184, Immunology of Viral, Autoimmune, Hematologic and Bacterial Diseases (IMVAHB), IDMIT Department/ IBFJ, Fontenay-aux-Roses, France.

Asier Sáez-Cirión (A)

Institut Pasteur, Université Paris Cité, Viral Reservoirs and Immune Control Unit, Paris, France.

Jérémie Guedj (J)

Université Paris Cité, IAME, INSERM, Paris, France.

Narendra M Dixit (NM)

Department of Chemical Engineering, Indian Institute of Science, Bengaluru, India.
Department of Bioengineering, Indian Institute of Science, Bengaluru, India.

Classifications MeSH